Latest Breaking News On - Cyrus harmon - Page 2 : comparemela.com

NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle s Institute for Protein Design – GeekWire

Vilya CEO Cyrus Harmon (Vilya Photo) Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced

David bakerCyrus harmonCyrus harmon vilyaInstitute for protein designVilya photoSeattle based instituteProtein designBay areaSeattle based madronaSilicon valley

HC Wainwright Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00

HC Wainwright Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsOlema pharmaceuticals company profileOlema pharmaceuticals trading downVanguard group incNews ratings for olema pharmaceuticals dailyOlema pharmaceuticalsVictory capital management incChina universal asset management coOlema pharmaceuticals incGoldman sachs groupSecurities exchange commissionHedge funds weigh in on olema pharmaceuticalsFree reportOne financialPharmaceuticals trading down

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyOlema pharmaceuticals company profileOlema pharmaceuticals incOlema pharmaceuticalsSecurities exchange commissionVivo capitalInstitutional investors weigh in on olema pharmaceuticalsDimensional fund advisorsVanguard group incOlema pharmaceuticals trading downGoldman sachs groupPolar capital holdings plcFree reportOne financial

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Director Cyrus Harmon Sells 5,000 Shares

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Director Cyrus Harmon Sells 5,000 Shares
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonVictory capital management incNews ratings for olema pharmaceuticals dailyOlema pharmaceuticals price performanceInstitutional investors weigh in on olema pharmaceuticalsPerceptive advisorsPolar capital holdings plcOlema pharmaceuticals incQuarter for olema pharmaceuticalsOlema pharmaceuticalsGoldman sachs groupFirst light asset managementGet free reportDirector cyrus harmonOne financialCapital holdings plc

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Stock

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonOlema pharmaceuticals company profileOlema pharmaceuticals incOlema pharmaceuticals stockSecurities exchange commissionGoldman sachs groupQuarter for olema pharmaceuticalsVictory capital management incVanguard group incNews ratings for olema pharmaceuticals dailyOlema pharmaceuticalsChina universal asset management coHedge funds weigh in on olema pharmaceuticalsGet free reportDirector cyrus harmonExchange commission